The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Microbiota transplantation: concept, methodology and strategy for its modernization
Open accessAbstract
Fecal microbiota transplantation (FMT) has become a research focus of biomedicine and clinical medicine in recent years. The clinical response from FMT for different diseases provided evidence for microbiota-host interactions associated with various disorders, including Clostridium difficile infection, inflammatory bowel disease, diabetes mellitus, cancer, liver cirrhosis, gut-brain disease and others. To discuss the experiences of using microbes to treat human diseases from ancient China to current era should be important in moving standardized FMT forward and achieving a better future. Here, we review the changing concept of microbiota transplantation from FMT to selective microbiota transplantation, methodology development of FMT and step-up FMT strategy based on literature and state experts' perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671 · cited 1×
“A new research found that gut microbiome improved efficacy of PD-1-based immunotherapy against epithelial tumors (Routy et al., 2018), implying that FMTcan be used to fight against cancer.”
BackgroundGibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634 · cited 1×
“A single microbe has a weak ability in the prevention and treatment of human diseases, though researches have proven its efficacy in standard animal models (Gibson et al., 2017).”
BackgroundGut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812 · cited 1×
“Another study (Gopalakrishnan et al., 2018) also demonstrated enhanced systemic immunity and favorable gut microbiome profile in patients showing good response to PD-1 immunotherapy, as well as in germ-free mice receiving fecal transplants from responding patients.”
BackgroundDuodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 1×
“In an RCT study, these two rates become 81% and 94% of resolution of CDI after the first FMT and repeat FMTs (van Nood et al., 2013).”
BackgroundThe Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637 · cited 2×
“Fecal microbiota transplantation (FMT), a concrete evidence proving the role of microbiota in many diseases, has recently become a research focus in biomedicine and clinical medicine (Khoruts and Sadowsky 2016; Lynch and Pedersen 2016; Vindigni and Surawicz 2017).”
BackgroundAnticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488 · cited 2×
“Infect Control Hosp Epidemiol 36:438–444 Vetizou M, Pitt JM, Daillere R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP et al (2015) Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.”
BackgroundThe commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J. J., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aao3290 · Cited by 3,107 · cited 1×
“A significant association has been observed between commensal microbial composition and clinical response of anti-PD-L1 therapy in metastatic melanoma patients (Matson et al., 2018).”
BackgroundVrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913 · cited 1×
“…reported the method and efficacy of using frozen fecal microbiota for C. difficile infection The improved methodology for storing fecal microbiota 2012 (Vrieze et al., 2012) Vrieze et al. from the Netherland reported the FMT in metabolic syndrome The evidence to use FMT in changing insulin…”
MethodFusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.008 · Cited by 2,198 · cited 1×
“The bioinformatic and functional studies demonstrated that Fusobacterium nucleatum enhanced the resistance of colorectal cancer to chemotherapy (Yu et al., 2017).”
BackgroundGuidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Research works printed but not linked: 2
- Ge H (2000) Zhou Hou Bei Ji Fang. Tianjin Science & Technology Press, Tianjin
- Xu R (2011) Chong Ding Tong Su Shang Han Lun. China Press of Traditional Chinese Medicine, Beijing
Cited by
A practical guide to amplicon and metagenomic analysis of microbiome data
Liu, Y.-X., Qin, Y., Chen, T., Lu, M., Qian, X., Guo, X., & Bai, Y. (2021) · Protein & Cell · doi:10.1007/s13238-020-00724-8 · Cited by 864
“…high-throughput sequencing (HTS) technology and data analysis methods, the roles of the microbiome in humans (Gao et al., 2018; Yang and Yu, 2018; Zhang et al., 2018a), animals (Liu et al., 2020), plants (Liu et al., 2019a; Wang et al., 2020a), and the environment (Mahnert et al., 2019; Zheng et…”
BackgroundMethodHigh-throughput cultivation and identification of bacteria from the plant root microbiota
Zhang, J., Liu, Y.-X., Guo, X., Qin, Y., Garrido-Oter, R., Schulze-Lefert, P., & Bai, Y. (2021) · Nature Protocols · doi:10.1038/s41596-020-00444-7 · Cited by 285
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Gut-Brain Psychology: Rethinking Psychology From the Microbiota–Gut–Brain Axis
Liang, S., Wu, X., & Jin, F. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00033 · Cited by 263
“…by microbiota intervention using probiotics, prebiotics, and FMT have increased steadily (Cryan and Dinan, 2012; Dinan et al., 2013; Liang et al., 2015; Pirbaglou et al., 2016; He et al., 2017; Kang et al., 2017; Mika et al., 2017; Zhao et al., 2017; Bruce-Keller et al., 2018; Yang et al., 2018).”
BackgroundZhang, T., Lu, G., Zhao, Z., Liu, Y., Shen, Q., Li, P., Chen, Y., Yin, H., Wang, H., Marcella, C., et al. (2020) · Protein & Cell · doi:10.1007/s13238-019-00684-8 · Cited by 260
“Themethod for preparation ofmicrobiota is basedon theautomatic microbiota purification system followed with centrifugation plus suspension for three times in a specially designed exclusive laboratory at goodmanufacture practice (GMP) level (Cui et al., 2016; Zhang et al., 2018).”
MethodInfluentialSelf-citation
Metadata
- Authors
- FMT-standardization Study Group, Zhang, F., Cui, B., He, X., Nie, Y., Wu, K., & Fan, D.
- Affiliations
- Sir Run Run Shaw Hospital (CN)
- First Affiliated Hospital of Guangdong Pharmaceutical University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Corresponding author
- Zhang, Faming
- Venue
- Protein & Cell
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-04-24
- Volume
- 9
- Issue
- 5
- Pages
- 462-473
- ISSN
- 1674-800X (ISSN-L)
- 1674-8018
- PMC
- PMC5960466
- OpenAlex
- W2800200239
- Semantic Scholar
- ff8600aed48167ea90e4a478426d6851b5788a7b
- Cited by
- 300
- References
- 105
- Citations by year
- 2026: 18 · 2025: 40 · 2024: 41 · 2023: 44 · 2022: 45 · 2021: 40 · 2020: 38 · 2019: 21 · 2018: 12
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Protein & Cell (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81600417, 81670495, 2015BAI13B07)
- Government of Jiangsu Province
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, microbiota-host interactions, Clostridium difficile infection, inflammatory bowel disease, diabetes mellitus, gut-brain axis
- MeSH terms
- Fecal Microbiota Transplantation, Host Microbial Interactions, Clostridium Infections, Humans, Metabolic Diseases, Inflammatory Bowel Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microbiota transplantation: concept, methodology and strategy for its modernization. https://app.cochat.ai/papers/10.1007/s13238-018-0541-8
- The paper
- FMT-standardization Study Group, Zhang, F., Cui, B., He, X., Nie, Y., Wu, K., & Fan, D. (2018). Microbiota transplantation: concept, methodology and strategy for its modernization. Protein & Cell. https://doi.org/10.1007/s13238-018-0541-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.